BWIN vs REGN
The Baldwin Insurance Group, Inc. (BWIN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
The Baldwin Insurance Group, Inc. (BWIN) is a insurance brokers company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported BWIN revenue for 2024-12-31 was $1.39B. Net income was -$41.1M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. BWIN currently screens at market cap $2.99B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
BWIN currently screens at market cap $2.99B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the BWIN and REGN stock pages for the full models.
Not investment advice.